habu health aims to be a global CANNABIS RESearch group, producing massive data powered by our users, and delivered via digital products.
Cannabis use represents the largest medical experiment in human history, yet nobody has been recording the results. Led by the brilliant neuroscientist, Dr. Adie Poe, habu health is creating technology that will finally record these valuable results and enable us to create massive intelligent data sets. Using scientific rigor, we will to be the first company to accurately connect cannabis plant characteristics with health ailments and recreational experiences. The data will also provide powerful insights for targeted product development, sales, and consumer preferences, which will transform the cannabis industry.
is a neuroscientist that has been granted millions of dollars for her research into how cannabis can lower the use of opioids. Dr. Poe is a global leader with over 10 years of fundamental research in cannabis, chronic pain, and opioid reduction. She is well known by her colleagues after winning numerous awards and conducting research at Washington State University, the University of Sydney in Australia, and Columbia University. She is currently a faculty member in the most well-funded department in the country at the prestigious Washington University in St. Louis.
Dr. Poe brings a truly unique set of expertise that is already benefitting the cannabis industry. Her knowledge of drug pharmacology, clinical trials, pain biology, and the brain’s mechanisms of addiction are very important to the improvement of cannabis science. Currently she is also working with congress on state and federal levels to reform medicinal cannabis legislature.
brings 20 years of experience in the marketing industry, with a specialty in business development, strategy, UX, and leadership. He has a proven business acumen and keen instincts for consumer targeting, lead generation, creative direction, and strategic brand partnerships.
Our co-founder, Dr. Adie Poe will be speaking on the morning of 2/15 about her research, and belief, that cannabis should no longer be referred to as "the gateway drug." Instead, we should credit cannabis as "the exit drug" as many studies have now shown how cannabis use can curb the dangerous use of powerful opioids.
On Wednesday, March 1st, our very own Dr. Poe was called to testify at the Missouri house of representatives in support of House Bill 437. This will would extend the benefits of medical cannabis in the state to patients with intractable diseases. Her testimony proved to be powerful, and popular with state legislators, many of which were tough skeptics on the medicinal benefits of cannabis.